Cartesian Therapeutics (1S70.F) Q4 2023 Earnings

7MarConfirmed
Q4 2023
-2.47
-1.92
-1.37
-0.82

Details

Expected EPS
-0.8218080000000001
Actual EPS
-2.465424
Surprise EPS
-1.64
Surprise Percent
+200%

Description

Cartesian Therapeutics (1S70.F) has reported earnings of -2.465424 per share for Q4 2023.

0 Comments

Share your thoughts